Work

Efficacy and safety of neoadjuvant therapy with stereotactic body radiation therapy followed by nab-paclitaxel/gemcitabine plus camrelizumab for resectable, borderline resectable and locally advanced pancreatic cancer: Preliminary results.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e16227

Authors: Jun Xue, Yue Hu, ShanMiao Gou, Tao Yin, Xin Li, Jing Wang, Hongli Liu, Ming Yang, Hong Ma, Jianli Hu, Zhenyu Lin, Pindong Li, Heshui Wu, Tao Zhang

Institutions: Huazhong University of Science and Technology, Wuhan Union Hospital

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Natural Science Foundation of China

OpenAlex ID: W4281671485

Cites:

Cited by:

Related to: 10